ORIGINAL ARTICLE

Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?

Ciara Barrett, Hilary Magee, Denise O’Toole, Sinead Daly and Michael Jeffers

Department of Cellular Pathology, The Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland

Correspondence to:
Correspondence to:
Dr M Jeffers
Laboratory Medicine Department, The Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland; michael.jeffers{at}amnch.ie

Background: The majority of cases of breast cancer scoring HER2 weak positive (2+) on immunohistochemistry (IHC) using the HercepTest are not associated with amplification of the HER2/neu gene.

Aim: To examine the reproducibility of IHC in cases scoring 2+ subsequently shown to have gene amplification by fluorescence in-situ hybridisation (FISH).

Methods: A retrospective analysis of 153 cases referred for FISH confirmation of a weak positive HercepTest (2+) result was performed. Repeat IHC was undertaken in cases with weak positive (2+) referral IHC and amplification of the HER2 gene by FISH.

Results: Amplification of the HER2 gene was confirmed in 29/153 cases (19%) scoring 2+ on IHC. Repeat IHC was carried out on 25 IHC 2+ cases: 7 (28%) scored 2+ on repeat IHC, 18 (72%) scored 3+ and were reclassified as strong positive. A heterogeneous expression pattern was present in 3/17 cases scoring 3+.

Conclusions: The majority of HercepTest 2+ results are not accompanied by gene amplification and represent "false positive" IHC in terms of prognostic or therapeutic relevance. A small proportion of HercepTest 2+ scores represent true 2+ IHC positive cases accompanied by gene amplification: a category probably biologically related to 3+ IHC cases. The remainder of cases of HercepTest^TM 2+ accompanied by gene amplification represent a category of referral IHC 2+ weak positive, FISH amplified, repeat IHC 3+ strong positive, best described as "false negative 2+ IHC". This has implications for selection of cases for FISH analysis where weak positive (2+) IHC score is used as a triage for FISH testing, and for testing strategies in referral laboratories undertaking FISH analysis.

Abbreviations: AMNCH, The Adelaide and Meath Hospital; FISH, fluorescence in-situ hybridisation; IHC, immunohistochemistry

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Minot, D. M., Kipp, B. R., Root, R. M., Meyer, R. G., Reynolds, C. A., Nassar, A., Henry, M. R., Clayton, A. C. (2009). Automated Cellular Imaging System III for Assessing HER2 Status in Breast Cancer Specimens: Development of a Standardized Scoring Method That Correlates With FISH. Am J Clin Pathol 132: 133-138 [Abstract] [Full Text]  
• Phipps, A. I., Malone, K. E., Porter, P. L., Daling, J. R., Li, C. I. (2008). Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal Women. Cancer Epidemiol. Biomarkers Prev. 17: 2078-2086 [Abstract] [Full Text]